Pediatric Acquired Heart Disease
Expert care for heart conditions that develop after birth
Overview
Not all pediatric heart disease is congenital. Conditions such as Kawasaki disease, myocarditis, cardiomyopathy, and rheumatic heart disease can develop in previously healthy children. Our team provides rapid diagnosis, evidence-based treatment, and long-term surveillance for the full spectrum of acquired pediatric cardiac conditions.
Common Acquired Conditions
Acquired heart disease in children includes Kawasaki disease (the leading cause of acquired heart disease in developed countries), viral and autoimmune myocarditis, dilated and hypertrophic cardiomyopathy, rheumatic heart disease, pericarditis, and infective endocarditis. Each condition has distinct diagnostic criteria, treatment pathways, and long-term implications that require pediatric cardiology expertise.
Diagnostic Approach
Accurate diagnosis often requires integrating clinical findings with echocardiography, cardiac MRI, biomarkers (troponin, BNP), inflammatory markers, and sometimes endomyocardial biopsy. For Kawasaki disease, coronary artery imaging is essential to detect aneurysm formation. For myocarditis, cardiac MRI with late gadolinium enhancement helps characterize the extent and pattern of myocardial injury.
Treatment Strategies
Treatment varies by condition — IVIG and aspirin for Kawasaki disease, immunosuppression for certain forms of myocarditis, heart failure medications for cardiomyopathy, and antibiotic prophylaxis for rheumatic heart disease. In severe cases, mechanical circulatory support or transplant evaluation may be necessary. Every treatment plan is individualized based on disease severity, response to initial therapy, and the child's overall clinical trajectory.
Long-Term Outcomes & Follow-Up
Many acquired heart conditions resolve completely, while others leave lasting cardiac effects that require ongoing surveillance. Children with coronary aneurysms from Kawasaki disease need lifelong imaging. Patients with cardiomyopathy require serial assessment of ventricular function and arrhythmia risk. Our follow-up protocols are designed to catch late complications early and support the best possible long-term outcomes.
Who Is This For?
- Children diagnosed with Kawasaki disease, myocarditis, or cardiomyopathy
- Families seeking evaluation for a child with new cardiac symptoms
- Patients with a history of acquired heart disease needing long-term follow-up
- Pediatricians seeking consultation for a child with suspected heart involvement